Dr. Oscar Perez is an Assistant Professor in the Pharmaceutical Sciences Department of the School of Pharmacy at Temple University. Dr. Perez’s expertise lies in molecular biology, genome editing, and biosensor development for drug discovery. In particular, he is highly experienced in developing cellular models to identify promising compounds for novel targets. He received his medical degree from Universidad del Norte in Colombia in 2002 and did his postdoctoral training in Biochemistry and Molecular Biology at Temple University (2005 – 2009). He has received research funding from NIH and the pharmaceutical industry. Dr. Perez is an inventor on four issued patents, including the FAST-HDR plasmid system used by ExpressCells. Dr. Perez received a Masters in Innovation Management and Entrepreneurship from the Fox School of Business at Temple University in 2015 and has strong interests in commercializing his academic inventions. Dr. Perez is the co-founder of two startup biotech companies, Recensa Therapeutics, and ExpressCells.